Winshine Science Co. Ltd. has announced a rights issue offering seven rights shares for every one existing share at a subscription price of HK$0.14 per rights share. The rights issue aims to raise gross proceeds of approximately HK$182.0 million, with net proceeds of around HK$176.5 million. Of the net proceeds, about HK$116.6 million will be used for the repayment of borrowings, and approximately HK$59.9 million will be allocated as general working capital. The rights issue was approved by independent shareholders at a special general meeting held on December 5, 2025.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Winshine Science Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251231-11972509), on December 31, 2025, and is solely responsible for the information contained therein.